March 05, 2025
Litigation firms accusing Pfizer of a scheme to inflate drug prices for Medicare and Medicaid plans saw their suit dismissed permanently, with a Washington, D.C., federal judge ruling they had been given "enough chances" to remedy pleading deficiencies in their claims.
April 04, 2023
A D.C. federal judge dismissed racketeering claims on Tuesday brought by five Medicare and Medicaid recovery companies accusing Pfizer and others of abusing independent charity patient assistance programs to drive up drug prices, saying too many "unsupported inferences" were required by the court.